Early efficacy and safety of anti–T-lymphocyte globulin (ATLG) induction therapy in renal transplant recipients in China: A multicenter, prospective observational study

Transplant Immunology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles